NO950602D0 - Antiangiogeniske oligomerer - Google Patents

Antiangiogeniske oligomerer

Info

Publication number
NO950602D0
NO950602D0 NO950602A NO950602A NO950602D0 NO 950602 D0 NO950602 D0 NO 950602D0 NO 950602 A NO950602 A NO 950602A NO 950602 A NO950602 A NO 950602A NO 950602 D0 NO950602 D0 NO 950602D0
Authority
NO
Norway
Prior art keywords
antiangiogenic
oligomers
antiangiogenic oligomers
Prior art date
Application number
NO950602A
Other languages
English (en)
Other versions
NO950602L (no
Inventor
Paul Steven Wright
Alan Joseph Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO950602L publication Critical patent/NO950602L/no
Publication of NO950602D0 publication Critical patent/NO950602D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
NO950602A 1992-08-19 1995-02-17 Antiangiogeniske oligomerer NO950602D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93211192A 1992-08-19 1992-08-19
PCT/US1993/006792 WO1994004165A1 (en) 1992-08-19 1993-07-20 Antiangiogenic oligomers

Publications (2)

Publication Number Publication Date
NO950602L NO950602L (no) 1995-02-17
NO950602D0 true NO950602D0 (no) 1995-02-17

Family

ID=25461789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950602A NO950602D0 (no) 1992-08-19 1995-02-17 Antiangiogeniske oligomerer

Country Status (12)

Country Link
US (1) US5593664A (no)
EP (1) EP0655923A1 (no)
JP (1) JPH08500590A (no)
AU (1) AU675961B2 (no)
CA (1) CA2142110A1 (no)
HU (1) HUT72993A (no)
IL (1) IL106707A (no)
MX (1) MX9305010A (no)
NO (1) NO950602D0 (no)
NZ (1) NZ254646A (no)
WO (1) WO1994004165A1 (no)
ZA (1) ZA935941B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0749690A1 (en) 1995-06-22 1996-12-27 Unilever N.V. Heat-settable, frozen bakery dough systems
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US20040022788A1 (en) 1998-05-19 2004-02-05 Moser Tammy L. Compositions and methods for promoting or inhibiting angiogenesis
IL140701A0 (en) 1998-07-13 2002-02-10 Univ Texas Cancer treatment methods using antibodies to aminophospholipids
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
GB0001481D0 (en) * 2000-01-21 2000-03-15 Theryte Ltd System for delivering a medicament
ES2358730T3 (es) 2002-07-15 2011-05-13 Board Of Regents, The University Of Texas System Anticuerpos seleccionados y péptidos de duramicina que se enlazan a fosfolípidos aniónicos y aminofosfolípidos y sus usos en el tratamiento de infecciones virales y del cáncer.
WO2005025515A2 (en) * 2003-09-12 2005-03-24 California Institute Of Technology Proteasome pathway inhibitors and related methods
CN1953743B (zh) 2004-01-22 2010-12-08 迈阿密大学 局部辅酶q10制剂及其使用方法
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
CA2737146A1 (en) 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
CN102382300B (zh) * 2011-10-11 2013-05-08 上海交通大学 一种水溶性磺化聚酰胺及其制备方法
WO2018145109A1 (en) 2017-02-06 2018-08-09 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US4027038A (en) * 1976-05-10 1977-05-31 American Cyanamid Company Complement inhibitors
US4087548A (en) * 1976-05-10 1978-05-02 American Cyanamid Company Complement inhibitors
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
WO1980000151A1 (en) * 1978-07-03 1980-02-07 American Home Prod N-(3-alkylaminopropyl)-n'-phenylureas
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4724235A (en) * 1981-05-20 1988-02-09 A. H. Robins Company, Incorporated N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4397868A (en) * 1982-01-26 1983-08-09 American Cyanamid Company Method of treating atherosclerosis with trisubstituted ureas
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US5019556A (en) * 1987-04-14 1991-05-28 President And Fellows Of Harvard College Inhibitors of angiogenin
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process

Also Published As

Publication number Publication date
EP0655923A1 (en) 1995-06-07
ZA935941B (en) 1994-03-10
IL106707A (en) 1997-02-18
NO950602L (no) 1995-02-17
MX9305010A (es) 1994-03-31
AU675961B2 (en) 1997-02-27
JPH08500590A (ja) 1996-01-23
NZ254646A (en) 1997-06-24
AU4684893A (en) 1994-03-15
HU9500493D0 (en) 1995-04-28
WO1994004165A1 (en) 1994-03-03
CA2142110A1 (en) 1994-03-03
US5593664A (en) 1997-01-14
HUT72993A (en) 1996-06-28
IL106707A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
AT399443B (de) Sportschuh
NO950602D0 (no) Antiangiogeniske oligomerer
DE69324297T2 (de) Hebemaschine
ATA236892A (de) Rotornut
DE69319985T2 (de) Personenrufempfänger
FI932281A (fi) Ettkaerlsfoerfarande
FI935587A0 (fi) Axelband foer damunderklaeder
ATA227792A (de) Sportschuh
BR9301712A (pt) Aplainador
KR940000228U (ko) 재치대
BR7201636U (pt) Disposicao em picador
ITFE920014V0 (it) Endolancet b
ATA25994A (de) Alpinski
BR9204065A (pt) Soprocóptero
ATA256392A (de) Bandräumer
FIU920031U0 (fi) Piparrangemang foer vaermecentral
SE9203303D0 (sv) Laada
BR9201149A (pt) Mutlimovel
BR7202026U (pt) Aero-mala
SE9201997D0 (sv) Maetmaskin
BR9204368A (pt) Auto-coletor
SE9201490D0 (sv) Behaallaroeppningsanordning
ATA27393A (de) Alpinski
BR9204204A (pt) Gabanto
BR9204074A (pt) Contramarco pre-moldano